Institutional investors control 16.08% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $21.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CPH CAPITAL FONDSMÆGLERSELSKAB A... Bought 923.4 Thousand shares of AstraZeneca PLC
CARNEGIE CAPITAL ASSET MANAGEMEN... Bought 17.7 Thousand shares of AstraZeneca PLC
HARVEST PORTFOLIOS GROUP, INC. Bought 14.4 Thousand shares of AstraZeneca PLC